Anti-tumor effect of ultrasound-induced Nordy-loaded microbubbles destruction

References

• Chen JH, Bian XW, Yao XH, et al. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells. Biochem Biophys Res Commun 2006;342:1368–74.
   PubMed Web of Science ®Google Scholar
• Bian XW, Yang SX, Chen JH, et al. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival by highly human and with patient. Neurosurgery 2007;61:570–8. Discussion 578–9.
   PubMed Web of Science ®Google Scholar
• Heller JD, Kuo J, Wu TC, et al. Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo. Cancer Res 2001;61:5499–504.
   PubMed Web of Science ®Google Scholar
• Chang CC, Heller JD, Kuo J, Huang RC. Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression. Proc Natl Acad Sci USA 2004;101:13239–44.
   PubMed Web of Science ®Google Scholar
• Yang X, Cui W, Yu S, et al. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model. PLoS One 2014;9:e85759.
   Google Scholar
• Wang B, Yu SC, Jiang JY, et al. An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells. Stem Cell Rev 2011;7:458–70.
   PubMed Web of Science ®Google Scholar
• Bian XW, Jiang XF, Chen JH, et al. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int Immunopharmacol 2006;6:90–9.
   PubMed Web of Science ®Google Scholar
• Ping YF, Yao XH, Chen JH, et al. The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells. J Neurooncol 2007;84:21–9.
   PubMed Web of Science ®Google Scholar
• Chen JH, Yao XH, Gong W, et al. A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors. J Neurooncol 2007;84:223–31.
   PubMed Web of Science ®Google Scholar
• Bian XW, Xu JP, Ping YF, et al. Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells. Proteomics 2008;8:484–94.
   PubMed Web of Science ®Google Scholar
• Zhang HR, Xu CP, Chen FL, Bian XW. Effect of nordy on the function of endothelial progenitor cells from human umbilical cord blood induced by vascular endothelial growth factor. Yao Xue Xue Bao 2008;43:133–7 (Chinese).
   PubMedGoogle Scholar
• Geers B, Dewitte H, De Smedt SC, Lentacker I. Crucial factors and emerging concepts in ultrasound-triggered drug delivery. J Control Release 2012;164:248–55.
   PubMed Web of Science ®Google Scholar
• Rapoport NY, Kennedy AM, Shea JE, et al. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009;138:268–76.
   PubMed Web of Science ®Google Scholar
• van Wamel A, Bouakaz A, Bernard B, et al. Controlled drug delivery with ultrasound and gas microbubbles. J Control Release 2005;101:389–91.
   PubMed Web of Science ®Google Scholar
• Shamout FE, Pouliopoulos AN, Lee P, et al. Enhancement of non-invasive trans-membrane drug delivery using ultrasound and microbubbles during physiologically relevant flow. Ultrasound Med Biol 2015;41:2435–48.
   Google Scholar
• Castle J, Feinstein SB. Drug and gene delivery using sonoporation for cardiovascular disease. Adv Exp Med Biol 2016;880:331–8.
   PubMed Web of Science ®Google Scholar
• Bouakaz A, Zeghimi A, Doinikov AA. Sonoporation: concept and mechanisms. Adv Exp Med Biol 2016;880:175–89.
   PubMed Web of Science ®Google Scholar
• Mao H, Yu S, Yu X, et al. Effect of coupled plasma filtration adsorption on endothelial cell function in patients with multiple organ dysfunction syndrome. Int J Artif Organs 2011;34:288–94.
   PubMed Web of Science ®Google Scholar
• Möbius C, Demuth C, Aigner T, et al. Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. Eur J Surg Oncol 2007;33:1025–9.
   PubMed Web of Science ®Google Scholar
• National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Research Council; 2011.
   Google Scholar
• Weidner N, Semple JP, Welch WR, Falkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma – in breast. N Engl J Med 1991;324:1–8.
   PubMed Web of Science ®Google Scholar
• Geis NA, Katus HA, Bekeredjian R. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des 2012;18:2166–83.
   PubMed Web of Science ®Google Scholar
• Tinkov S, Bekeredjian R, Winter G, Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009;98:1935–61.
   PubMed Web of Science ®Google Scholar
• Hua X, Liu P, Gao YH, et al. Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: a primary research. J Thromb Thrombolysis 2010;30:29–35.
   PubMed Web of Science ®Google Scholar
• Hua X, Zhou L, Liu P, et al. In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model. J Thromb Thrombolysis 2014;38:57–64.
   PubMed Web of Science ®Google Scholar
• Postema M, Gilja OH. Contrast-enhanced and targeted ultrasound. World J Gastroenterol 2011;17:28–41.
   PubMed Web of Science ®Google Scholar
• Eisenbrey JR, Forsberg F. Contrast-enhanced ultrasound for molecular imaging of angiogenesis. Eur J Nucl Med Mol Imaging 2010;37:S138–46.
   Google Scholar
• Unger EC, Matsunaga TO, McCreery T, et al. Therapeutic applications of microbubbles. Eur J Radiol 2002;42:160–8.
   PubMed Web of Science ®Google Scholar
• Cochran MC, Eisenbrey J, Ouma RO, et al. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 2011;414:161–70.
   PubMed Web of Science ®Google Scholar
• Yan F, Li X, Jin Q, et al. Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells. Ultrasound Med Biol 2011;37:768–79.
   Google Scholar
• Kuo F, Histed S, Xu B, et al. Immuno-PET imaging of tumor endothelial marker 8 (TEM8). Mol Pharm 2014;11:3996–4006.
   PubMed Web of Science ®Google Scholar
• Mehran R, Nilsson M, Khajavi M, et al. Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy. Cancer Res 2014;74:2731–41.
   PubMed Web of Science ®Google Scholar
• Wallace N, Wrenn SP. Ultrasound triggered drug delivery with liposomal nested microbubbles. Ultrasonics 2015;63:31–8.
   PubMed Web of Science ®Google Scholar
• Skachkov I, Luan Y, van der Steen AF, et al. Targeted microbubble mediated sonoporation of endothelial cells in vivo. IEEE Trans Ultrason Ferroelectr Freq Control 2014;61:1661–7.
   PubMed Web of Science ®Google Scholar
• Delalande A, Kotopoulis S, Postema M, et al. Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene 2013;525:191–9.
   PubMed Web of Science ®Google Scholar
• Fan Z, Kumon RE, Deng CX. Mechanisms of microbubble-facilitated sonoporation for drug and gene delivery. Ther Deliv 2014;5:467–86.
   PubMedGoogle Scholar
• Kooiman K, Vos HJ, Versluis M, de Jong N. Acoustic behavior of microbubbles and implications for drug delivery. Adv Drug Deliv Rev 2014;72:28–48.
   PubMed Web of Science ®Google Scholar
• Husseini GA, Pitt WG, Martins AM. Ultrasonically triggered drug delivery: breaking the barrier. Colloids Surf B Biointerfaces 2014;123:364–86.
   PubMed Web of Science ®Google Scholar
• Shi F, Yang F, He X, et al. Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells. J Drug Target 2015;23:1–13.
   PubMed Web of Science ®Google Scholar
• Abdalkader R, Kawakami S, Unga J, et al. Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumor model. Acta Biomater 2015;19:112–18.
   PubMed Web of Science ®Google Scholar